Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
29.9M
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
4.61M
-
Shares change
-
-152K
-
Total reported value, excl. options
-
$78.1M
-
Value change
-
-$131K
-
Number of buys
-
11
-
Number of sells
-
-19
-
Price
-
$16.94
Significant Holders of Profound Medical Corp. - Common Shares (PROF) as of Q2 2020
38 filings reported holding PROF - Profound Medical Corp. - Common Shares as of Q2 2020.
Profound Medical Corp. - Common Shares (PROF) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.61M shares
of 29.9M outstanding shares and own 15.44% of the company stock.
Largest 10 shareholders include FIL Ltd (895K shares), GAGNON SECURITIES LLC (732K shares), PURA VIDA INVESTMENTS, LLC (574K shares), Redmile Group, LLC (400K shares), AWM Investment Company, Inc. (349K shares), ROYCE & ASSOCIATES LP (293K shares), Gagnon Advisors, LLC (257K shares), Zweig-DiMenna Associates LLC (187K shares), Blackcrane Capital, LLC (175K shares), and RTW INVESTMENTS, LP (174K shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.